Skip to main content

Ryan Beechinor, PharmD, BCPS, CPP

Hematology/Oncology Pharmacy Resident, University of North Carolina (UNC) Medical Center, Chapel Hill

Authored Items

A Pipeline Preview of 2016 FDA Approvals in Hematology/Oncology
By Ryan Beechinor, PharmD, BCPS, CPP; John M. Valgus, PharmD, MHA, BCOP
2016 First Annual Oncology Guide to New FDA Approvals
FDA Approvals
The year 2015 marked a noteworthy 12-month period for oncology drugs approved by the US Food and Drug Administration (FDA). The Center for Drug Evaluation and Research, which reviews the approval of antibodies and small molecules, approved a total of 45 new drugs in 2015; 15 of which are indicated for the treatment of cancer. Read More ›